Patient-Centric Trials
Patient-centric trials, also known as patient-centered trials, are a relatively new approach to clinical trials that aim to put the needs and experiences of patients at the center of the trial process. Traditional clinical trials have often been criticized for being too focused on meeting the needs of researchers, regulators, and sponsors, rather than on the needs and preferences of the patients who participate in the trials.
Patient-centric trials are designed to address these concerns by incorporating patient perspectives and priorities throughout the trial process. This can include involving patients in the trial design process, developing trial protocols that are more patient-friendly, and providing patients with more information and support during the trial.
One key aspect of patient-centric trials is patient engagement. This means involving patients in the trial process from the beginning, and throughout the trial. For example, patients may be involved in developing the trial design, selecting outcomes that are important to them, and providing feedback on the trial procedures and materials.
Another important aspect is the use of patient-reported outcomes (PROs). PROs are measures that capture how patients feel and function and can provide important insights into the impact of a treatment on patients’ lives. By incorporating PROs into the trial design, researchers can gain a better understanding of how patients experience the treatment being studied.
Patient-centric trials also focus on making the trial process more convenient and less burdensome for patients. This can include providing transportation, arranging childcare, and offering support services such as counseling and education. These extra steps can help your trial go a long way, and be more successful.
Overall, patient-centric trials represent a significant shift in the way clinical trials are conducted, with a greater emphasis on patient needs and perspectives. This approach has the potential to improve the efficiency and effectiveness of clinical trials, while also improving patient satisfaction and engagement.